Dextropropoxyphene: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 23: Line 23:


{{medicine-stub}}
{{medicine-stub}}
<gallery>
File:Dextropropoxyphene_structure.svg|Chemical structure of Dextropropoxyphene
File:Dextropropoxyphene3DanJ.gif|3D model of Dextropropoxyphene
File:propoxyphene.jpg|Dextropropoxyphene
File:propoxyphene2.jpg|Dextropropoxyphene
</gallery>

Latest revision as of 04:59, 18 February 2025

Dextropropoxyphene is a narcotic analgesic that was previously used in the treatment of mild to moderate pain. It is a synthetic opioid that is structurally related to methadone. Dextropropoxyphene was withdrawn from the market in many countries, including the United States, due to concerns about its safety and effectiveness.

Pharmacology[edit]

Dextropropoxyphene acts primarily as a mu-opioid receptor agonist. It also has weak norepinephrine reuptake inhibiting properties. The drug is metabolized in the liver, primarily by the cytochrome P450 enzyme system, and its metabolites are excreted in the urine.

Medical uses[edit]

Dextropropoxyphene was used for the relief of mild to moderate pain, either alone or in combination with acetaminophen (paracetamol) or aspirin. It was also used as a cough suppressant and an antidiarrheal agent.

Side effects[edit]

Common side effects of dextropropoxyphene include dizziness, sedation, nausea, and vomiting. More serious side effects can include respiratory depression, cardiac arrhythmia, and seizures. Overdose can lead to severe respiratory depression and death.

History[edit]

Dextropropoxyphene was first synthesized in the United States in the 1950s. It was marketed under various brand names, including Darvon and Dolene. In 2010, the FDA requested that all products containing dextropropoxyphene be withdrawn from the market due to concerns about the drug's safety and effectiveness.

See also[edit]


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!